Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study

Introduction: The Coronavirus Disease 2019 (COVID-19) pandemic has been caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The most important approach to prevent severe disease progression and to contain the pandemic is the use of COVID-19 vaccines. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollenberg, Richard, Tepasse, Phil-Robin, Lorentzen, Eva, Nowacki, Tobias Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146879/
https://www.ncbi.nlm.nih.gov/pubmed/35629116
http://dx.doi.org/10.3390/jpm12050694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146879/
https://www.ncbi.nlm.nih.gov/pubmed/35629116
http://dx.doi.org/10.3390/jpm12050694

Ejemplares similares